Andrew A. Somogyi
Affiliations: | University of Adelaide, Adelaide, South Australia, Australia |
Area:
Clinical Pharmacology, Pharmacogenomics, Pharmacokinetics, PharmacyGoogle:
"Andrew Somogyi"Mean distance: 20.4 (cluster 58)
Cross-listing: Chemistry Tree
Children
Sign in to add trainee| Mark Rowland Hutchinson | grad student | 1999-2004 | University of Adelaide |
| Peter M. Grace | grad student | 2007-2011 |
Collaborators
Sign in to add collaborator| Mark Rowland Hutchinson | collaborator | 2007- | University of Adelaide |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Hu R, Barratt DT, Coller JK, et al. (2019) A short communication: Is there a temporal relationship between trough whole blood tacrolimus concentration and acute rejection in the first 14 days after kidney transplantation? Therapeutic Drug Monitoring |
| Somogyi AA, Barratt DT, Phillips EJ, et al. (2019) High and variable population prevalence of HLA-B*56:02 in Indigenous Australians and relation to phenytoin-associated DRESS. British Journal of Clinical Pharmacology |
| Sallustio BC, Noll BD, Coller JK, et al. (2019) Relationship between allograft cyclosporin concentrations and P-glycoprotein expression in the first month following renal transplantation. British Journal of Clinical Pharmacology |
| Hu R, Barratt DT, Coller JK, et al. (2018) Effect of tacrolimus dispositional genetics on acute rejection in the first 2 weeks and estimated glomerular filtration rate in the first 3 months following kidney transplantation. Pharmacogenetics and Genomics |
| Md Dom ZI, Coller JK, Carroll RP, et al. (2018) Mycophenolic Acid Concentrations in Peripheral Blood Mononuclear Cells are Associated with the Incidence of Rejection in Renal Transplant Recipients. British Journal of Clinical Pharmacology |
| Tucci JD, Pumuye PP, Helsby NA, et al. (2018) Pharmacogenomics in Papua New Guineans: unique profiles and implications for enhancing drug efficacy while improving drug safety. Pharmacogenetics and Genomics. 28: 153-164 |
| Hu R, Barratt DT, Coller JK, et al. (2018) CYP3A5*3 and ABCB1 61A>G Significantly Influence Dose-adjusted Trough Blood Tacrolimus Concentrations in the First Three Months Post Kidney Transplantation. Basic & Clinical Pharmacology & Toxicology |
| Athanasos P, Ling W, Bochner F, et al. (2018) Buprenorphine Maintenance Subjects Are Hyperalgesic and Have No Antinociceptive Response to a Very High Morphine Dose. Pain Medicine (Malden, Mass.) |
| Newcombe DAL, Somogyi AA, Bochner F, et al. (2017) Impaired Psychomotor Function and Plasma Methadone and Levo-Alpha-Acetylmethadol (LAAM) Concentrations in Opioid-Substitution Patients. Experimental and Clinical Psychopharmacology |
| Barratt DT, Cox HK, Menelaou A, et al. (2016) CYP2C8 Genotype Significantly Alters Imatinib Metabolism in Chronic Myeloid Leukaemia Patients. Clinical Pharmacokinetics |